Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Chỉ hiển thị Multimedia

Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years
18 Oct 2025
bởiMike Ng
Patients with schizophrenia who either continued on the LAI paliperidone palmitate (PP) 6-monthly for up to 3 years or transitioned from PP 3-monthly treatment have sustained symptomatic and functional remission, as shown in a post hoc analysis of the single-arm, OLE study PSY3016
Paliperidone 6-month LAI sustains symptomatic, functional remission in schizophrenia at 3 years
18 Oct 2025
Tirzepatide proves safety, efficacy in T1D in real world
09 Oct 2025
bởiStephen Padilla
The use of tirzepatide in a real-world setting demonstrates a favourable safety profile and results in weight loss, lower insulin requirements, and better glycaemic measurements among patients with type 1 diabetes (T1D), as shown in a study presented at EASD 2025.